{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:05Z","timestamp":1787162525089,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1472-6874-11-15","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T14:48:04Z","timestamp":1305902884000},"source":"Crossref","is-referenced-by-count":20,"title":["A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk"],"prefix":"10.1186","volume":"11","author":[{"given":"Kristina M","family":"Blackmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"234_CR1","first-page":"3","volume":"16","author":"JI Jones","year":"1995","unstructured":"Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995, 16: 3-34.","journal-title":"Endocr Rev"},{"key":"234_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1677\/joe.0.1400165","volume":"140","author":"JM Holly","year":"1994","unstructured":"Holly JM, Hughes SC: Measuring insulin-like growth factors: why, where and how?. J Endocrinol. 1994, 140: 165-169. 10.1677\/joe.0.1400165.","journal-title":"J Endocrinol"},{"key":"234_CR3","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"363","author":"AG Renehan","year":"2004","unstructured":"Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M: Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet. 2004, 363: 1346-1353. 10.1016\/S0140-6736(04)16044-3.","journal-title":"The Lancet"},{"key":"234_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1677\/erc.1.01219","volume":"13","author":"AG Renehan","year":"2006","unstructured":"Renehan AG, Harvie M, Howell A: Insulin-like growth factor (IGF)-1, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer. 2006, 13: 273-278. 10.1677\/erc.1.01219.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"234_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1055-9965.2.14.1","volume":"14","author":"O Fletcher","year":"2005","unstructured":"Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JMP, Ashworth A, Peto J, dos Santos Silva I: Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review. Cancer Epidemiol Biomarkers Prev. 2005, 14 (1): 2-19.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"234_CR6","first-page":"345","volume":"9","author":"E Giovannucci","year":"2000","unstructured":"Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE: A prospective Study of Plasma Insulin-Like Growth Factor-1 and Binding Portein-3 and Risk of Colorectal Neoplasia in Women. Cancer Epidemiol Biomarkers Prev. 2000, 9: 345-349.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"234_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/jnci\/92.19.1592","volume":"92","author":"R Kaaks","year":"2000","unstructured":"Kaaks R, Toniolo P, Akhmedkhanov A: Serum C-peptide, insulin-like growth factor(IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000, 92: 1592-1600. 10.1093\/jnci\/92.19.1592.","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 3","key":"234_CR8","first-page":"49","volume":"58","author":"P Geusens","year":"2002","unstructured":"Geusens P, Boonen S: Osteoporosis and the Growth Hormone-Insulin-Like Growth Factor Axis. Horm Res. 2002, 58 (suppl 3): 49-55.","journal-title":"Horm Res"},{"key":"234_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00774-007-0799-z","volume":"26","author":"J Liu","year":"2008","unstructured":"Liu J, Zhao H, Ning G, Chen Y, Zhang L, Sun L, Zhao Y, Xu M, Chen J: IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women. J Bone Miner Metab. 2008, 26: 159-164. 10.1007\/s00774-007-0799-z.","journal-title":"J Bone Miner Metab"},{"key":"234_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.CIR.0000027563.44593.CC","volume":"106","author":"A Juul","year":"2002","unstructured":"Juul A, Scheike T, Davidsen MJ, Gyllenborg T, Jorgensen JO: Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease: a population based case control study. Circulation. 2002, 106: 939-944. 10.1161\/01.CIR.0000027563.44593.CC.","journal-title":"Circulation"},{"key":"234_CR11","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1210\/jc.2004-2088","volume":"90","author":"SP Johnsen","year":"2005","unstructured":"Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjonneland A, Overvad K, Jorgensen JO: Insulin-like growth factor (IGF-1-II), and IGF-1 binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab. 2005, 90: 5937-5941. 10.1210\/jc.2004-2088.","journal-title":"J Clin Endocrinol Metab"},{"key":"234_CR12","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0959-8049(00)00102-7","volume":"36","author":"M Pollack","year":"2000","unstructured":"Pollack M: Insulin-like growth factor physiology and cancer risk. Eur J Cancer. 2000, 36: 1224-1228. 10.1016\/S0959-8049(00)00102-7.","journal-title":"Eur J Cancer"},{"issue":"5","key":"234_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E: Growth Hormone, Insulin-Like Growth Factors, and the Skeleton. Endocr Rev. 2008, 29 (5): 535-559. 10.1210\/er.2007-0036.","journal-title":"Endocr Rev"},{"key":"234_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2265.2008.03292.x","volume":"69","author":"A Colao","year":"2008","unstructured":"Colao A: The GH-IGF-1 axis and the cardiovascular system: clinical implications. Clin Endocrinol. 2008, 69: 347-358. 10.1111\/j.1365-2265.2008.03292.x.","journal-title":"Clin Endocrinol"},{"key":"234_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/00008469-200110000-00008","volume":"10","author":"A Lukanova","year":"2001","unstructured":"Lukanova A, Toniolo P, Akhmedkhanov A, Hunt K, Rinaldi S, Zeleniuch-Jacquotte A, Haley NJ, Riboli E, Stattin P, Lundin E, Kaaks R: A cross-sectional study of IGF-1 determinants in women. Eur J Cancer Prev. 2001, 10: 443-452. 10.1097\/00008469-200110000-00008.","journal-title":"Eur J Cancer Prev"},{"key":"234_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1023\/A:1013708627664","volume":"12","author":"DW Voskuil","year":"2001","unstructured":"Voskuil DW, Bas Bueno de Mesquita H, Kaaks R, van Noord P, Rinaldi S, Rioli E, Grobbee DE, Peeters PHM: Determinants of circulating insulin-like growth factor(IGF)-1 and IGF binding proteins1-3 in premenopausal women: physical activity and anthropometry. Cancer Causes Control. 2001, 12: 951-958. 10.1023\/A:1013708627664.","journal-title":"Cancer Causes Control"},{"key":"234_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1022518321634","volume":"14","author":"NE Allen","year":"2003","unstructured":"Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, Key TJ: Lifestyle determinants of serum insulin-like growth factor-1, C-peptide and hormone binding protein levels in British women. Cancer Causes Control. 2003, 14: 65-74. 10.1023\/A:1022518321634.","journal-title":"Cancer Causes Control"},{"issue":"9","key":"234_CR18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1158\/1055-9965.EPI-04-0944","volume":"14","author":"SP Pinheiro","year":"2005","unstructured":"Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE: Racial Differences in Premenopausal Endogenous Hormones. Cancer Epidemiol Biomarkers Prev. 2005, 14 (9): 2147-2153. 10.1158\/1055-9965.EPI-04-0944.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"234_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1677\/ERC-06-0080","volume":"14","author":"ES Schernhammer","year":"2007","unstructured":"Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE: Body shape throughout life and correlation with IGFs and GH. Endocr Relat Cancer. 2007, 14: 721-732. 10.1677\/ERC-06-0080.","journal-title":"Endocr Relat Cancer"},{"key":"234_CR20","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1210\/jc.81.11.3986","volume":"81","author":"A Eliakim","year":"1996","unstructured":"Eliakim A, Brasel JA, Subburaman Mohan, Barstow TJ, Berman N, Cooper DM: Physical Fitness, Endurance Training and the Growth Hormone-Insulin-Like Growth Factor 1 System in Adolescent Females. J Clin Endocrinol Metab. 1996, 81: 3986-3992. 10.1210\/jc.81.11.3986.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"234_CR21","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/1055-9965.2264.13.12","volume":"13","author":"JA Lavigne","year":"2004","unstructured":"Lavigne JA, Wimbrow HH, Clevidence BA, Albert PS, Reichman ME, Campbell WS, Barrett JC, Hursting SD, Judd JT, Taylor PR: Effects of Alcohol and Menstrual Cycle on Insulin-like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3. Cancer Epidemiol Biomarkers Prev. 2004, 13 (12): 2264-2267.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"234_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00394-004-0500-4","volume":"44","author":"G Maskarinec","year":"2005","unstructured":"Maskarinec G, Takata Y, Kaaks R: The relation between nutritional factors and insulin-like growth factor-1 in premenopausal women of different ethnicity. Eur J Nutr. 2005, 44: 105-113. 10.1007\/s00394-004-0500-4.","journal-title":"Eur J Nutr"},{"key":"234_CR23","first-page":"377","volume":"10","author":"H Jernstrom","year":"2001","unstructured":"Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M: Genetic and Nongenetic Factors Associated with Variation of Plasma Levels of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding-Protein-3 in Healthy Premenopausal Women. Cancer Epidemiol Biomarkers Prev. 2001, 10: 377-384.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"234_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0002-9378(99)70249-8","volume":"180","author":"M Westwood","year":"1999","unstructured":"Westwood M, Gibson JM, Pennells LA, White A: Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle. Am J Obstet Gynecol. 1999, 180: 530-536. 10.1016\/S0002-9378(99)70249-8.","journal-title":"Am J Obstet Gynecol"},{"key":"234_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0010-7824(00)00176-1","volume":"62","author":"A Balogh","year":"2000","unstructured":"Balogh A, Kauf E, Vollanth R, Graser G, Klinger G, Oettel M: Effects of two oral contraceptives on plasma levels of insulin-like growth factor 1 (IGF-1) and growth hormone (hGH). Contraception. 2000, 62: 259-269. 10.1016\/S0010-7824(00)00176-1.","journal-title":"Contraception"},{"key":"234_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.4065\/81.10.1290","volume":"81","author":"C Kahlenborn","year":"2006","unstructured":"Kahlenborn C, Modugno F, Potter DM, Severs WB: Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-analysis. Mayo Clin Proc. 2006, 81: 1290-1302. 10.4065\/81.10.1290.","journal-title":"Mayo Clin Proc"},{"key":"234_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4065\/83.1.86","volume":"83","author":"PM Casey","year":"2008","unstructured":"Casey PM, Cerhan JR, Pruthi S: Oral Contraceptive Use and the Risk of Breast Cancer. Mayo Clin Proc. 2008, 83: 86-91. 10.4065\/83.1.86.","journal-title":"Mayo Clin Proc"},{"key":"234_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"EE Calle","year":"1996","unstructured":"Calle EE, Heath CW, Miracle-McMahill HL, Coates RJ: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. The Lancet. 1996, 347: 1713-1727.","journal-title":"The Lancet"},{"key":"234_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1054\/bjoc.2000.1622","volume":"84","author":"E Fernandez","year":"2001","unstructured":"Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E: Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer. 2001, 84: 722-727. 10.1054\/bjoc.2000.1622.","journal-title":"Br J Cancer"},{"key":"234_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/humupd\/dmp017","volume":"15","author":"C Bosetti","year":"2009","unstructured":"Bosetti C, Bravi F, Negri E, La Vecchia C: Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update. 2009, 15: 489-498. 10.1093\/humupd\/dmp017.","journal-title":"Hum Reprod Update"},{"key":"234_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bjsm.2005.020065","volume":"40","author":"SL Liu","year":"2006","unstructured":"Liu SL, Lebrun CM: Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and postmenopausal women: a systematic review. Br J Sports Med. 2006, 40: 11-24. 10.1136\/bjsm.2005.020065.","journal-title":"Br J Sports Med"},{"key":"234_CR32","first-page":"1023","volume":"165","author":"JC Prior","year":"2001","unstructured":"Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA, Adachi JD, Vigna YM, Berger C, Blondeau L, Jackson SA, Tenenhouse A: Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population based data from the Canadian Multicenter Osteoporosis Study. CMAJ. 2001, 165: 1023-1029.","journal-title":"CMAJ"},{"key":"234_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bone.2006.08.001","volume":"40","author":"M Hartard","year":"2007","unstructured":"Hartard M, Kleinmond C, Wiseman M, Weissenbacher ER, Felsenberg D, Erben RG: Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone. 2007, 40: 444-450. 10.1016\/j.bone.2006.08.001.","journal-title":"Bone"},{"key":"234_CR34","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1210\/jc.2004-1958","volume":"90","author":"JP Baillargeon","year":"2005","unstructured":"Baillargeon JP, McClish DK, Essah PA, Nestler JE: Association Between the Current Use of Low Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis. J Clin Endocrinol Metab. 2005, 90: 3863-3870. 10.1210\/jc.2004-1958.","journal-title":"J Clin Endocrinol Metab"},{"key":"234_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","volume":"68","author":"YS Khader","year":"2003","unstructured":"Khader YS, Rice J, John L, Abueita O: Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003, 68: 11-17. 10.1016\/S0010-7824(03)00073-8.","journal-title":"Contraception"},{"key":"234_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jama.284.1.72","volume":"284","author":"LA Gillum","year":"2000","unstructured":"Gillum LA, Mamidipudi SK, Johnston SC: Ishemic Stroke Risk With Oral Contraceptives: A Meta-analysis. JAMA. 2000, 284: 72-78. 10.1001\/jama.284.1.72.","journal-title":"JAMA"},{"key":"234_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00003","volume":"127","author":"SM Schwartz","year":"1997","unstructured":"Schwartz SM, Siscovick DS, Longstreth WT, Psaty BM, Beverly RK, Raghunathan TE, Lin D, Koepsell TD: Use of Low-Dose Oral Contraceptives and Stroke in Young Women. Ann Intern Med. 1997, 127: 596-603.","journal-title":"Ann Intern Med"},{"key":"234_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1118\/1.3276737","volume":"37","author":"JA Knight","year":"2010","unstructured":"Knight JA, Blackmore KM, Wong J, Tharmalingam S, Lilge L: Optical spectroscopy of the breast in premenopausal women reveals tissue variation with changes in age and parity. Med Phys. 2010, 37: 419-426. 10.1118\/1.3276737.","journal-title":"Med Phys"},{"key":"234_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036193","volume":"17","author":"SD Harlow","year":"1995","unstructured":"Harlow SD, Ephross SA: Epidemiology of Menstruation and Its Relevance to Women's Health. Epidemiol Rev. 1995, 17: 265-286.","journal-title":"Epidemiol Rev"},{"key":"234_CR40","first-page":"2073","volume":"60","author":"S Cereh-Suhl","year":"1999","unstructured":"Cereh-Suhl S, Yeager BF: Update on Oral Contraceptive Pills. Am Fam Physician. 1999, 60: 2073-2084.","journal-title":"Am Fam Physician"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-11-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-11-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:50:35Z","timestamp":1686077435000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-11-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-11-15","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]},"article-number":"15"}}